✦ LIBER ✦

Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab

✍ Scribed by Nalan Akyurek; Aysegul Uner; Mustafa Benekli; Ibrahim Barista

Book ID: 112067068
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 399 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27396

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epratuzumab with rituximab, cyclophospha

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

✍ Micallef, I. N. M.; Maurer, M. J.; Wiseman, G. A.; Nikcevich, D. A.; Kurtin, P. 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 193 KB

Bcl-2, Bcl-6, and the International Prog

Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy

✍ Akiko Miyagi Maeshima; Hirokazu Taniguchi; Suguru Fukuhara; Noriyuki Morikawa; W 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB

MYC and BCL2 protein expression predicts

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab

✍ Perry, Anamarija M.; Alvarado-Bernal, Yuridia; Laurini, Javier A.; Smith, Lynett 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

Intrathecal methotrexate prophylaxis and

Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone

✍ Tomita, Naoto; Takasaki, Hirotaka; Ishiyama, Yasufumi; Kishimoto, Kumiko; Ishiba 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 351 KB

Prognostic importance of BCL6 rearrangem

Prognostic importance of BCL6 rearrangements in diffuse large B-cell lymphoma with respect to Bcl6 protein levels and primary lymphoma site

✍ Alexandar Tzankov; Aurelia Schneider; Sylvia Hoeller; Stephan Dirnhofer 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Cost utility in the United States of rit

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma

✍ John C. Hornberger; Jennie H. Best 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views